Hormonal effect on psoriasis in pregnancy and postpartum
J.E. Murase, K.K. Chan, T.J. Garite, D.M. Cooper, and G.D. Weinstein Hormonal effect on psoriasis in pregnancy and postpartum Arch Dermatol 141 2005 601 606
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: Potential relevance to psoriasis
C.Q.F. Wang, Y.T. Akalu, M. Suarez-Farinas, J. Gonzalez, H. Mitsui, and M.A. Lowes et al. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis J Invest Dermatol 133 2013 2741 2752
A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drugs Administration database
J.D. Carter, A. Ladhani, L.R. Ricca, J. Valeriano, and F.B. Vasey A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drugs Administration database J Rheumatol 36 2009 635 641
Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: Results from a national population register
K.L. Hyrich, D.P.M. Symmons, K.D. Watson, and A.J. Silman Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register Arthritis Rheum 54 2006 2701 2702
Psoriasis induced by anti-tumor necrosis factor therapy: A paradoxical adverse reaction
P.P. Sfikakis, A. Iliopoulos, A. Elezoglou, C. Kittas, and A. Stratigos Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction Arthritis Rheum 52 2005 2513 2518
Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions
G.C. De Gannes, M. Ghoreishi, J. Pope, A. Russell, D. Bell, and S. Adams et al. Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions Arch Dermatol 143 2007 223 231